Long-Term Efficacy of Vedolizumab in Pediatric Inflammatory Bowel Disease

被引：0
|
作者：
Sarles, Harry E., Jr.
Whitney, Annette E.
Kuten, Samantha A.
Van Anglen, Lucinda J.
机构：
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2019年 / 114卷
关键词：
D O I：
10.14309/01.ajg.0000594116.32306.0b
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1147
引用
收藏
页码：S643 / S644
页数：2
相关论文
共 50 条
  • [31] VEDOLIZUMAB LEVELS DURING INDUCTION ARE ASSOCIATED WITH LONG-TERM CLINICAL AND ENDOSCOPIC REMISSION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Yarur, Andres J.
    Bruss, Alexandra
    Berens, Brandon
    Fox, Caroline
    Beniwal-Patel, Poonam M.
    Patel, Amir
    Ungaro, Ryan C.
    Dubinsky, Marla
    Naik, Snehal
    Stein, Daniel J.
    GASTROENTEROLOGY, 2018, 154 (06) : S827 - S828
  • [32] Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases
    Andres J. Yarur
    Alexandra Bruss
    Snehal Naik
    Poonam Beniwal-Patel
    Caroline Fox
    Anjali Jain
    Brandon Berens
    Amir Patel
    Ryan Ungaro
    Bayda Bahur
    Marla Dubinsky
    Daniel J. Stein
    Digestive Diseases and Sciences, 2019, 64 : 1651 - 1659
  • [33] Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases
    Yarur, Andres J.
    Bruss, Alexandra
    Naik, Snehal
    Beniwal-Patel, Poonam
    Fox, Caroline
    Jain, Anjali
    Berens, Brandon
    Patel, Amir
    Ungaro, Ryan
    Bahur, Bayda
    Dubinsky, Marla
    Stein, Daniel J.
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (06) : 1651 - 1659
  • [34] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Hsu, Diane
    Lee, Justin
    Kotzen, Alison
    Bensen, Rachel
    Goyal, Alka
    INFLAMMATORY BOWEL DISEASES, 2024, 30 : S73 - S74
  • [35] ANTI-TNF EFFICACY AFTER PRIMARY VEDOLIZUMAB FAILURE IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
    Dolinger, Michael
    Rolfes, Priya
    Phan, Becky
    Pan, Stephanie
    Dubinsky, Marla
    GASTROENTEROLOGY, 2020, 158 (03) : S116 - S116
  • [36] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Anjur, Kavya
    Neiman, Nicole
    Kotzen, Alison
    Pond, Stephen
    Goyal, Alka
    GASTROENTEROLOGY, 2022, 162 (07) : S826 - S826
  • [37] ITALIAN REAL-LIFE STUDY EVALUATING THE LONG-TERM EFFECTIVENESS OF VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
    Pugliese, Daniela
    Privitera, Giuseppe
    Armuzzi, Alessandro
    GASTROENTEROLOGY, 2023, 164 (06) : S1119 - S1120
  • [38] ITALIAN REAL-LIFE STUDY EVALUATING THE LONG-TERM EFFECTIVENESS OF VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
    Pugliese, Daniela
    Privitera, Giuseppe
    Armuzzi, Alessandro
    GASTROENTEROLOGY, 2021, 160 (06) : S700 - S701
  • [39] Long-term Efficacy of Vedolizumab for Ulcerative Colitis
    Loftus, Edward V., Jr.
    Colombel, Jean-Frederic
    Feagan, Brian G.
    Vermeire, Severine
    Sandborn, William J.
    Sands, Bruce E.
    Danese, Silvio
    D'Haens, Geert R.
    Kaser, Arthur
    Panaccione, Remo
    Rubin, David T.
    Shafran, Ira
    McAuliffe, Megan
    Kaviya, Arpeat
    Sankoh, Serap
    Mody, Reema
    Abhyankar, Brihad
    Smyth, Michael
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (04): : 400 - 411
  • [40] Long-Term Safety and Efficacy of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease
    Mock, Joseph D.
    Tuskey, Anne G.
    Rubin, Amy
    Behm, Brian W.
    GASTROENTEROLOGY, 2015, 148 (04) : S257 - S257
12345